Vimarsana
Biggest News Aggregation in the World

Page 8 - Cm Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Life Sciences Today - Breaking & Trending Today

Growth Signals: Sema4 Navigates Precision Medicine with $500M SPAC - Vimarsana News

Growth Signals: Sema4 Navigates Precision Medicine with $500M SPAC

Growth Signals: Sema4 Navigates Precision Medicine with $500M SPAC Founder and CEO Eric Schadt, PhD, discusses the genomic and clinical data company’s approach to ‘health intelligence’ with GEN Edge. July 26, 2021 Eric Schadt, PhD, Sema4’s Founder and CEO, says his company’s going public through a just-completed $500 million SPAC deal will enhance its competitiveness as it strives to offer more holistic precision medicine solutions for health systems and biopharmas. The company employs just over 1,000 people. [Sema4] Share Sema4 has signaled its intent to grow into a juggernaut of p...

De-SPACs Get Set to Join the Russell 3000 - Vimarsana News

De-SPACs Get Set to Join the Russell 3000

The improved SPAC narrative continues with June's deal votes going smoothly, CCIV getting a vote date, CCIV/Lucid setting a vote date, and the Russell 3k welcoming a number of de-SPACs to its ranks.

Market Players Are Looking to Put More Cash to Work - Vimarsana News

Market Players Are Looking to Put More Cash to Work

Speculative trading has lost energy, and there is some rotation back into big-cap value names....ARKK

This Picker's on the Prowl: Here's What I'm Trading - Vimarsana News

This Picker's on the Prowl: Here's What I'm Trading

This Picker's on the Prowl: Here's What I'm Trading...AMC

SPACs End Week on a High (Kind of) - Vimarsana News

SPACs End Week on a High (Kind of)

SPACs End Week on a High (Kind of) The SPAC market is still stuck in a kind of stasis with most SPACs meaningfully below NAV, or for a rare few with deals fighting to stay above, but at least it didn't get worse today. Author: ** Investors saw the broader market rebound from a dismal few days with the S&P up 1.49% and the NASDAQ up 2.32% and even SPACs showed some lift. That said, the average pre-deal SPAC is still trading at $9.83 -- well below NAV. Yesterday we pointed out that the pitchforks are out for Chamath and SPACs and today will have been a nice, if minor, respite for both.